2025 / 02

Next Paper
DOI: 10.24075/brsmu.2025.023
Copyright: © 2025 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).

ORIGINAL RESEARCH

Comparison of extracorporeal photopheresis and glatiramer acetate efficacy in the treatment of multiple sclerosis

Kildyushevsky AV, Kotov SV, Sidorova OP, Borodin AV, Bunak MS
About authors

Vladimirsky Moscow Regional Research and Clinical Institute, Moscow, Russia

Correspondence should be addressed: Olga P. Sidorova
Shhepkina 61/2, Moscow, 129110, Russia; sidorovaop2019@mail

About paper

Author contribution: Kildyushevsky AV — study planning, literature review, extracorporeal photopheresis (transimmunization), data interpretation, manuscript writing; Kotov SV — study planning, literature review, data interpretation, manuscript writing; Sidorova OP — literature review, data acquisition and interpretation, patient assessment using EDSS, manuscript writing; Borodin AV — literature review, data acquisition and interpretation, patient assessment using EDSS, manuscript writing; Bunak MS — literature review, data acquisition and interpretation, MRI, manuscript writing.

Compliance with ethical standards: the study was approved by the Ethics Committee (protocol No. 16 dated 26 November 2020); the informed consent to participation in the study was submitted by all subjects.

Received: 2025-04-02 Accepted: 2025-04-19 Published online: 2025-04-29
|
  1. Edelson R, Berger C, Gasparro F, Jegasothy B, Heald P, Wintroub B, et al. New therapies for cutaneous T-cell lymphoma. N Engl J Med. 1987; 316 (6): 297–303. DOI: 10.1056/NEJM198702053160603.
  2. Michallet M, Sobh M, Deloire A, Revesz D, Chelgoum Y, El-Hamri M. Second line extracorporeal photopheresis for cortico-resistant acute and chronic GVHD after allogeneic hematopoietic cell transplantation for hematological malignancies: Long-term results from a real-life study. Transfus Apher Sci. 2024; 63 (3): 103899. DOI: 10.1016/j.transci.2024.103899.
  3. Rastogi S, Kim EJ, Gelfand JM, Loren AW, Baumrin E. Chronic Graft-versus-Host Disease-Associated Muscle Cramps: Severity and Response to Immunomodulatory Therapies. Transplant Cell Ther. 2024; 30 (3): 338.e1–338.e6. DOI: 10.1016/j.jtct.2023.12.674.
  4. Kim D, Taparia M, Robinson E, Mcgee M, Merali T. Navigating the Complexity of Chronic Graft-vs-Host Disease: Canadian Insights into Real-World Treatment Sequencing.Transplant Proc. 2024; 56 (2): 409–15. DOI: 10.1016/j.transproceed.2023.12.021.
  5. Ruf T, Rahimi F, Anz D, Tufman A, Salzer S, Zierold S, et al. Extracorporeal Photopheresis as a Treatment Option for Immune-Related Adverse Events: Two Case Reports and a Prospective Study. J Immunother. 2024. DOI: 10.1097/CJI.0000000000000510.
  6. Lin Y, Cheng Z, Zhong Y, Zhao Y, Xiang G, Li L, et al. Extracorporeal photopheresis reduces inflammation and joint damage in a rheumatoid arthritis murine model. J Transl Med. 2024; 22 (1): 305. DOI: 10.1186/s12967-024-05105-x.
  7. Fisher AJ, White M, Goudie N, Kershaw A, Phillipson J, Bardgett M, et al. Extracorporeal photopheresis (ECP) in the treatment of chronic lung allograft dysfunction (CLAD): a prospective, multicentre, open-label, randomised controlled trial studying the addition of ECP to standard care in the treatment of bilateral lung transplant patients with CLAD (E-CLAD UK). BMJ Open Respir Res. 2024; 11 (1): e001995. DOI: 10.1136/bmjresp-2023-001995.
  8. Lionet A, Van Triempon M, Figeac M, Fages V, Gibier JB, Provot F, et al. Extracorporeal Photopheresis Reduces Fibrotic and Inflammatory Transcriptomic Biological Marker of Chronic Antibody-mediated Kidney Rejection. Transplant Direct. 2024; 10 (3): e1587. DOI: 10.1097/TXD.0000000000001587.
  9. Mitsunaga K, Bagot M, Ram-Wolff C, Guenova E, von Gugelberg C, Hodak E, et al. Real-world study on the use of pegylated interferon alpha-2a for treatment of mycosis fungoides/Sézary syndrome using Time to Next Treatment as a measure of clinical benefit: An EORTC CLTG study. Br J Dermatol. 2024: 152. DOI: 10.1093/bjd/ljae152.
  10. Castillo-Aleman YM, Krystkowiak PC. Extracorporeal photopheresis in stiff person syndrome. Front Immunol. 2024; 15: 1519032. DOI: 10.3389/fimmu.2024.1519032. eCollection 2024.
  11. Szabó BG, Reményi P, Tasnády S, Korózs D, Gopcsa L, Réti M, et al. Extracorporeal Photopheresis as a Possible Therapeutic Approach for Adults with Severe and Critical COVID-19 NonResponsive to Standard Treatment: A Pilot Investigational Study. J Clin Med. 2023; 12 (15): 5000. DOI: 10.3390/jcm12155000.
  12. Kildyushevsky AV, Molochkov AV, Zhuravlev OR, Mitina TA, Belousov KA, Zakharov SG, et al. Jekstrakorporal'nyj fotoferez v lechenii novogo koronavirusnogo zabolevanija COVID-19 (serija klinicheskih nabljudenij). Al'manah klinicheskoj medicinyju. 2020; 48 (Specvypusk 1): 11–19. DOI: 10.18786/2072-0505-2020-48-039. Russian.
  13. Neretin V Ya, Kildyushevsky AV, Agafonov BV, Geht BM, Sidorova OP, Ospennikova TP. Fotoferez — novyj metod lechenija miastenii. Zhurnal nevrologii i psihiatrii im. S. S. Korsakova. 2002; 103 (6): 11–14. PMID: 12872619. Russian.
  14. Rathod DG, Muneer H, Masood S. Phototherapy In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. PMID: 33085287.
  15. Lolli F, Liuzzi GM, Vergelli M, Massacesi L, Ballerini C, Amaducci L, et al. Antibodies specific for the lipid-bound form of myelin basic protein during experimental autoimmune encephalomyelitis. J Neuroimmunol. 1993; 44: 69–75. DOI: 10.1016/0165-5728(93)90269-5.
  16. Cavaletti G, Perseghin P, Dassi M, Oggioni N, Sala F, Lolli F, et al. Extracorporeal photochemopherapy reduces the incidence of relapses in experimental allergic encephalomyelitis in DA rats. J Neurol. 2001; 248 (6): 535–6. DOI: 10.1007/s004150170169.
  17. Cavaletti G, Perseghin P, Buscemi F, Dassi M, Oggioni N, Sala F, et al. Immunomodulationg effects of extracorporeal photochemotherapy (ECP) in rats experimental allergic encephalomyelitis (EAE). Int J Tissue React. 2001; 23 (1): 21–31. PMID: 11392060.
  18. Cavaletti G, Perseghin P, Dassi M, Oggioni N, Sala F, Braga M, et al. Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells. J Biol Regul Homeost Agents. 2004; 18 (1): 9–17. PMID: 15323355.
  19. Cavaletti G, Perdeghin P, Dassi M, Oggioni N, Sala F, Braga M, et al. Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells. J Biological Regulators and Homeostatic Agents. 2004; 18 (1): 9–17. PMID: 15323355.
  20. Cavaletti G, Perseghin P, Dassi M, Cavarretta R, Frigo M, Caputo D, et al. Extracorporeal photochemotherapy: a safety and tolerability pilot study with preliminary efficacy results in refractory relapsing-remitting multiple sclerosis. Neurol Sci. 2006; 27 (1): 24–32. PubMed PMID: 16688596.
  21. Extracorporeal photopheresis: Medical Coverage Guidelines of the Blue Cross and Blue Shield Association of Arizona. 2012; 5 p.
  22. Ninosu N, Melchers S, Kappenstein M, Booken N, Hansen I, Blanchard M, et al. Mogamulizumab Combined with Extracorporeal Photopheresis as a Novel Therapy in Erythrodermic Cutaneous T-cell Lymphoma. Cancers (Basel). 2023; 27–16 (1): 141. DOI: 10.3390/cancers16010141.
  23. Neretin VYa, Kildyushevsky AV, Ozerova IV, Kotov SV, Golenkov AK. Method of treatment of patients with autoimmune diseases. The 2000 Russian patent on IPC A61M1/38 A61N5/06 2000-11-27. Publication 1999–01–29. Russian.
  24. Neretin VYa, Kotov SV, Kildyushevsky AV, Sidorova OP, Ozerova IV. Jekstrakorporal'naja fotohimioterapija v lechenii bol'nyh rassejannym sklerozom. Uchebnoe posobie. M.: MONIKI, 2003; 11 s. Russian.
  25. Ozerova IV, Kotov SV, Neretin VYa, Kildyushevsky AV. Jekstrakorporal'naja fotohimioterapija v lechenii bol'nyh rassejannym sklerozom. V sbornike: Materialy k Respublikanskomu rabochemu soveshhaniju «Voprosy diagnostiki i lechenija demielinizirujushhih zabolevanij nervnoj sistemy»; 23–24 fevralja 1999. Stupino; s. 180– 182. Russian.